Goodwin Procter-Led Biotech Completes €30M Acquisition
Paris-listed Valerio Therapeutics said Monday it has completed its acquisition of Belgian vaccines technology company Etherna in a cash and shares transaction worth approximately €30 million ($33.5 million)....To view the full article, register now.
Already a subscriber? Click here to view full article